Logo: Four dots and StockDot set in typeface Coolvetica
An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for IONIS PHARMACEUTICALS Inc
Ticker IONS
FIGI BBG000JH6683
CUSIP 462222100
Sector Healthcare
Equity Type Common Stock
No. Companies Holding this Equity 334 / 4.8%
Percentage held by institutional investors 99.4%

About

Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.The company was named Isis Pharmaceuticals until December 2015. Wikipedia